Related Experiment Videos
[Encephalomyelitis disseminata: clinical aspects, pathogenesis and current therapy concepts]
S Merkelbach1, C Kölmel, K Schimrigk
1Neurologische Klinik, Universitätskliniken Homburg/Saar. merkelb1@hotmail.com
Der Radiologe
|January 9, 2001
Summary
Multiple sclerosis (MS) is an autoimmune disease targeting the central nervous system. Treatments focus on modulating the immune system to manage symptoms and slow disease progression.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
Context:
- Multiple sclerosis (MS) is a T-cell mediated autoimmune disorder.
- Characterized by central nervous system demyelination and axonal damage.
- Presents with relapsing-remitting or chronic progressive courses.
Purpose:
- To summarize clinical symptoms and diagnostic criteria for MS.
- To outline the pathogenetic considerations of MS.
- To review current immunomodulative and immunosuppressive therapies for MS.
Summary:
- MS involves T-cell mediated autoimmune attack on the CNS.
- Clinical manifestations vary, including demyelination and axonal damage.
- Therapeutic strategies aim to control disease progression through immunomodulation and immunosuppression.
Impact:
- Provides a comprehensive overview of MS pathogenesis and treatment.
- Aids clinicians in understanding and managing MS.
- Highlights the importance of immunomodulatory approaches in MS therapy.